Dr Martin Frisher

Title: Reader in Health Services Research
Phone: 01782 733568
Email:
Location: Hornbeam Building, Room 1.48
Role:
Contacting me: Try my office or arrange an appointment by e-mail

I joined the Department of Medicines Management in 1997. My background is in psychology and epidemiology and my research interests include drug addiction, medical decision making and prescribing analysis. I oversee the research modules and teach the Psychology of Addiction module. I am member of the Independent Scientific Committee on Drugs (ISCD) http://www.drugscience.org.uk/

Selected Publications

  • Coxon DE, Frisher M, Jordan KP, Jinks C, Peat G. 2012. DECIDING TO CONSULT THE GENERAL PRACTITIONER FOR SYMPTOMATIC OSTEOARTHRITIS: A CHOICE-BASED CONJOINT ANALYSIS STUDY. RHEUMATOLOGY (vol. 51, p. 37). link>
  • Frisher M, Baldacchino A, Crome I, Bloor R. 2012. Preventing opioid overdoses in Europe: a critical assessment of known risk factors and preventative measures. link>
  • Frisher M, Short D, Bashford J. 2010. Determining patient characteristics for decision analysis support systems using anonymized electronic patient records. Health Informatics J, vol. 16(1), 49-57. link> doi>
  • Frisher M. 2010. The science and politics of cannabis, drugs and schizophrenia - Commentary on: Cannabis causes schizophrenia? So does nicotine. ADDICTION RESEARCH & THEORY, vol. 18(6), 609-611. link> doi>
  • Frisher M, Crome I, Martino O, Croft P. 2009. Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005. Schizophr Res, vol. 113(2-3), 123-128. link> doi>

Full Publications List show

Journal Articles

  • Frisher M, Short D, Bashford J. 2010. Determining patient characteristics for decision analysis support systems using anonymized electronic patient records. Health Informatics J, vol. 16(1), 49-57. link> doi>
  • Frisher M. 2010. The science and politics of cannabis, drugs and schizophrenia - Commentary on: Cannabis causes schizophrenia? So does nicotine. ADDICTION RESEARCH & THEORY, vol. 18(6), 609-611. link> doi>
  • Frisher M, Crome I, Martino O, Croft P. 2009. Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005. Schizophr Res, vol. 113(2-3), 123-128. link> doi>
  • Frisher M, Martino O, Crome I, Croft P. 2009. Response to Stevens and Reuter. J Public Health (Oxf). doi> link>
  • Frisher M, Martino O, Crome I, Croft P. 2009. Trends in drug misuse recorded in primary care in the UK from 1998 to 2005. J Public Health (Oxf), vol. 31(1), 69-73. link> doi>
  • Frisher M and Forsyth A. 2009. Assessing the validity of recent estimates of problematic drug use in England. J Epidemiol Community Health, vol. 63(1), 87-88. link> doi> full text>
  • Frisher M and Martino,O,Crome,I.. 2009. Croft response to Stevens and Reuter Frisher et al. J Public Health, vol. 31, 309-310.
  • Newman CGJ, Crome I, Frisher M. 2009. REVEALING THE ROLE OF CONTEXT, EXPERIENCE AND INDIVIDUAL DIFFERENCES IN THE ASSESSMENT OF HEROIN ADDICTS' DECISION MAKING ABILITIES. EUROPEAN PSYCHIATRY, vol. 24. link>
  • Crome IB, Bloor R, Frisher M. 2008. Symposium: Alcoholism and substance misuse in psychiatric emergency. EUROPEAN PSYCHIATRY, vol. 23, S21. link> doi>
  • Crome IB, Bloor R, Frisher M. 2008. Self-harm and substance misuse in the UK - key issues for treatment and research. DRUGS-EDUCATION PREVENTION AND POLICY, vol. 15(2), 121-127. link> doi>
  • Frisher M. 2007. Vision for the future? A commentary on 'Sociology and Substance Use' by McKeganey et al. (2005). DRUGS-EDUCATION PREVENTION AND POLICY, vol. 14(5), 457-465. link> doi>
  • Newman CGJ, Crome I, Frisher M. 2007. The impact of feedback and punishment on the decisions of male heroin addicts. EUROPEAN PSYCHIATRY, vol. 22, S194-S195. link> doi>
  • Frisher M, Heatlie H, Hickman M. 2007. Validating estimates of problematic drug use in England. BMC Public Health, vol. 7, 286. link> doi> full text>
  • Frischer M. 2006. Forecasting drug use. Internation Journal of Drug Policy, vol. 17, 159-163. doi>
  • FRISHER M, Heatlie H, Hickman M. 2006. Prevalence of problematic and injecting drug use for Drug Action Team areas in England. Journal of Public Health, vol. 28(1), 3-9. doi>
  • FRISHER M and Beckett H. 2006. Drug use desistance. Criminology and Criminal Justice, vol. 6(1), 127-145. doi>
  • Frischer M. 2006. Forecasting Drug use: Commentary on "Recent spread of Heroin Use in the United States" by Leon. G Hunt. International Journal of Drug Policy, vol. 17(3), 159-163.
  • Frisher M, Crome I, Macleod J, Millson D, Croft P. 2005. Substance misuse and psychiatric illness: prospective observational study using the general practice research database. J Epidemiol Community Health, vol. 59(10), 847-850. link> doi> full text>
  • Short D and Frischer M. 2004. Supporting the evidence based treatment of individual drug users: The case for 'patient profile decision analysis'. International Journal of Drug Policy. doi>
  • FRISHER M, Crome I, Green C, Willoughby R. 2005. Individual and population risk of drug use among adolescents attending an English Youth Offending Team: An epidemiological approach. Journal of Forensic Psychiatry & Psychology, vol. 16(1), 11-23. doi>
  • Crome I, Newman C, Frisher M. 2005. Neuroimaging and addiction. EUROPEAN PSYCHIATRY, vol. 20, S20. link>
  • Short D, Frischer M, Bashford J. 2004. Barriers to the adoption of computerised decision support systems in general practice consultations: a qualitative study of GPs' perspectives. Int J Med Inform, vol. 73(4), 357-362. link> doi>
  • SHORT D, FRISCHER M, BASHFORD J. 2004. Barriers to the adoption of computerised decision support systems in general practice consultations: A qualitative study of GPs' perspectives. International Journal of Medical Informatics.
  • Frischer M, Collin M, Millson DS, Crome I, Croft P. 2004. Prevalence of comorbid psychiatric illness and substance misuse in primary care in England and Wales. Journal of Epidemiological Community Health, vol. 58(12), 1035-1041.
  • FRISCHER M, COLLINS J, MILLSON D, CROME I, CROFT P. 2004. Prevalence of comorbid psychiatric illness and substance misuse in primary care in England and Wales. Journal of Epidemiological Community Health. doi>
  • Short D, Frischer M, Bashford J, Ashcroft D. 2003. Why are eligible patients not prescribed aspirin in primary care? A qualitative study indicating measures for improvement. BMC Fam Pract, vol. 4, 9. link> doi>
  • Kraus L, Augustin R, Frischer M, Kummler P, Uhl A, Wiessing L. 2003. Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction, vol. 98(4), 471-485. doi>
  • Short D, Frischer M, Bashford J. 2003. The development and evaluation of a computerised decision support system for primary care based upon 'patient profile decision analysis'. Informatics in Primary Care, vol. 11(4), 195-202.
  • Short D, Frischer M, Bashford J. 2003. The development and evaluation of a computerised decision support system for primary care based upon 'patient profile decision analysis'. Inform Prim Care, vol. 11(4), 195-202. link>
  • SHORT D, FRISCHER M, BASHFORD J, ASHCROFT D. 2003. Why are eligible patients not prescribed aspirin in primary care? A qualitative study indicating measures for improvement. BMC Family Practice.
  • Ashcroft DM, Frischer M, Lockett J, Chapman SR. 2002. Variations in prescribing atypical antipsychotic drugs in primary care: cross-sectional study. Pharmacoepidemiol Drug Saf, vol. 11(4), 285-289. link> doi>
  • Frischer M, Anderson S, Hickman M, Heatlie H. 2002. Diffusion of drug misuse in Scotland: Findings from the 1993 and 1996 Scottish Crime Surveys. Addiction Research. doi>
  • McKeever TM, Lewis SA, Smith C, Collins J, Heatlie H, Frischer M, Hubbard R. 2002. Early exposure to infections and antibiotics and the incidence of allergic disease: A birth cohort study with the West Midlands General Practice Research Database. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 109(1), 43-50. link> doi>
  • McKeever T, Lewis S, Smith C, Collins J, Heatlie H, Frischer M, et A. 2002. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. Journal of Allergy and Clinical Immunology.
  • Hickman M, Taylor C, Chatterjee A, Degenhardt L, Frisher M, Hay G. 2002. Estimating drug prevalence: Review of methods with special reference to developing countries. UN bulletin on narcotics, vol. LIV, 15-33.
  • Short D, Frischer M, Bashford J. 2002. Explaining risks: The importance of GPs' understanding. BMJ.
  • Wyatt KM, Dimmock PW, Frischer M, Jones PW, O'Brien PMS. 2002. Prescribing patterns in Premenstrual Syndrome. Biomed Central Women's Health.
  • Short D, Frischer M, Bashford J. 2002. The Development Of A Computerised Decision Support System To Assist GP Prescribing In The Secondary Prevention Of Stroke. Pharmacoepidemiology and Drug Safety, vol. 11, 142.
  • Ashcroft D, Frischer M, Lockett J, Chapman S. 2002. Variations in prescribing atypical antipsychotic drugs in primary care: cross-sectional study. Pharmacoepidemiology and Drug Safety.
  • McKeever TM, Lewis SA, Smith C, Collins J, Heatlie H, Frischer M, Hubbard R. 2001. Siblings, multiple births, and the incidence of allergic disease: a birth cohort study using the West Midlands general practice research database. Thorax, vol. 56(10), 758-762. link> doi>
  • Frischer M, Hickman H, Kraus L, Mariani F, Wiessing L. 2001. A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain. Addiction. doi>
  • Ditton J and Frischer M. 2001. Computerised projection of future heroin epidemics: A necessity for the 21st Century. Journal of Substance Use and Abuse. doi>
  • Frischer M and Akram G. 2001. Prevalence of comorbid mental illness and drug use recorded in general practice: preliminary findings from the General Practice Research Database. Drugs: education, prevention and policy.
  • McKeever T, Lewis S, Smith C, Collins J, Heatlie H, Frischer M, Hubbard R. 2001. Siblings, multiple births and the incidence of allergic disease: A birth cohort study using the West Midlands General Practice Research Database. Thorax.
  • Frischer M, Norwood J, Bashford J, Millson D, Chapman S. 2001. Trends in antibiotic prescribing and associated indications in primary care from 1993-1997. Journal of Public Health Medicine. doi>
  • Frischer M, Norwood J, Bashford J, Millson D, Chapman S. 2001. Trends in antibiotic prescribing and associated indications in primary care from 1993-1997. Journal of Public Health Medicine.
  • Millson D, Frischer M, Croft P, Goadsby PJ. 2000. Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness?. Cephalalgia, vol. 20(8), 732-737. link> doi>
  • Frischer M, Norwood J, Heatlie H, Millson D, Lowdell J, Hickman M, Chapman S, Bashford J. 2000. A comparison of trends in problematic drug misuse from two reporting systems. J Public Health Med, vol. 22(3), 362-367. link> doi>
  • Hutchinson SJ, Gore SM, Taylor A, Goldberg DJ, Frischer M. 2000. Extent and contributing factors of drug expenditure of injectors in Glasgow. Multi-site city-wide cross-sectional study. Br J Psychiatry, vol. 176, 166-172. link> doi>
  • Millson DS, Frischer M, Croft P, Goadsby PJ. 2000. Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness?. Cephalalgia, vol. 20, 1-8.
  • Frischer M, Heatlie HF, Chapman S, Millson DS. 2000. Defining the spectrum of appropriate prescribing: implications for effective medicines management. International Journal of Pharmaceutical Medicine, vol. 14, 17-21.
  • Hutchinson S, Gore S, Taylor A, Goldberg D, Frischer M. 2000. Extent and contributing factors of drug expenditure of drug injectors in Glasgow. British Medical Journal, vol. 176, 166-172.
  • Frischer M, Heatlie HF, Chapman S, Bashford J, Norwood J. 2000. Prescribing of inhalers in airways disease: An analysis of age-specific rates and switching between delivery systems. Journal of Applied Therapeutic Research, vol. 2, 253-259.
  • Frischer M, Heatlie H, Chapman S, Bashford J, Norwood J, Millson D. 2000. Ratio of inhaled corticosteroid to bronchodilator treatment and asthma hospitalisation. Curr Med Res Opin, vol. 16(1), 8-13. link>
  • Frischer M, Heatlie HF, Chapman S, Bashford J, Norwood J, Millson DS. 2000. Ratio of inhaled corticosteroid to broncholilator and hospital referral for asthma. Drugs: Education, Prevention and Policy, vol. 16(1), 8-13.
  • Chapman S, Heatlie HF, Frischer M, Bashford J. 2000. Using the General Practice Research Database to generate and "at risk register" for a primary care stroke prevention programe. Value in Health, vol. 3(5).
  • Hickman M, Cox S, Harvey J, Howes S, Farrell M, Frischer M, Stimson G, Taylor C, Tilling K. 1999. Estimating the prevalence of problem drug use in inner London: a discussion of three capture-recapture studies. Addiction, vol. 94(11), 1653-1662. link> doi>
  • Frischer M, Heatlie H, Chapman S, Norwood J, Bashford J, Millson D. 1999. Should the corticosteroid to bronchodilator ratio be promoted as a quality prescribing marker?. Public Health, vol. 113(5), 247-250. link> doi>
  • Frischer M and Blenkinsopp A. 1999. A critical appraisal of current issues and research in the Uk. Critical Public Health, vol. 9, 181-195.
  • Blenkinsopp A, Phelan M, Bourne J, Frischer M, Dakhil N. 1999. Can control of blood pressure be improved by an intervention by community pharmacists?. Pharmaceutical Journal, vol. 263, R16.
  • Gore S and Frischer M. 1999. Effective Monitoring of young people's use of illegal drugs: meta-analysis of UK trends and recommendations. British Journal of Criminology, vol. 39, 575-584.
  • Hickman M, Cox S, Harvey J, Howes S, Farrell M, Frischer M, Stimson G, Taylor C. 1999. Estimating the prevalence of problem drug use in inner-London. Addiction, vol. 94(11), 1653-1662.
  • Frischer M and Blenkinsopp A. 1999. Medicine misuse or abuse? A critical appraisal of current issues and research in the UK. Critical Public Health, vol. 9, 181-195.
  • Frischer M, Heatlie HF, Chapman S, Bashford J, Norwood J. 1999. Switching between metered dose inhalers (MDIs) and dry powder inhalers (DPIs) in airways disease: an analysis of age-specific rates using the General Practice Research Database. Journal of Applied Therapeutic Research, vol. 2, 253-259.
  • Blenkinsopp A, Phelan M, Bourne J, Frischer M. 1999. What is the effect on patient satisfaction of an intervention by community pharmacists?. Pharmaceutical Journal, vol. 263, R16-R17.
  • Frischer M, Chapman S, Bashford J, Norwood J, Heatlie HF. 1998. General practice research database for prescribing analysis. Lancet, vol. 351, 453-454. doi>
  • Frischer M, Chapman S, Bashford J, Norwood J, Heatlie H. 1998. General Practice Research Database for prescribing analysis. Lancet, vol. 351(9100), 453-454. link> doi>
  • Clark W, Frischer M, Misson J. 1998. Data available before products are launched are poor. BMJ, vol. 316, 228-229.
  • Frischer M, Goldberg D, Rahman M, Berney L. 1997. Mortality and survival among a cohort of drug injectors in Glasgow, 1982-1994. Addiction, vol. 92(4), 419-427. link> doi>
  • Frischer M and Goldberg D. 1997. Estimating the incidence and prevalence of injecting drug use in Glasgow. Addiction Research, vol. 5, 307-315. doi>
  • Taylor A, Frischer M, Goldberg D. 1996. Non-fatal overdosing is related to polydrug use in Glasgow. BMJ, vol. 313(7069), 1400-1401. link>
  • Frischer M, Taylor A, Goldberg D, Elliott L. 1996. Direct evaluation of needle and syringe exchange programmes. Lancet, vol. 347(9003), 768. link> doi>
  • Des Jarlais DC, Hagan H, Friedman SR, Friedmann P, Goldberg D, Frischer M, Green S, Tunving K, Ljungberg B, Wodak A. 1995. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA, vol. 274(15), 1226-1231. link> doi>
  • McKeganey N, Abel M, Taylor A, Frischer M, Goldberg D, Green S. 1995. The preparedness to share injecting equipment: an analysis using vignettes. Addiction, vol. 90(9), 1253-1260. link> doi>
  • Des Jarlais DC, Friedman SR, Friedmann P, Wenston J, Sotheran JL, Choopanya K, Vanichseni S, Raktham S, Goldberg D, Frischer M. 1995. HIV/AIDS-related behavior change among injecting drug users in different national settings. AIDS, vol. 9(6), 611-617. link>
  • Green ST, Goldberg DJ, Frischer M, Cameron S, Taylor A, Gruer L. 1995. Measuring HIV-1 infection among needle/syringe exchange attenders. Am J Med, vol. 98(6), 596-598. link> doi>
  • BARNARD M and FRISCHER M. 1995. COMBINING QUANTITATIVE AND QUALITATIVE APPROACHES - RESEARCHING HIV-RELATED RISK BEHAVIORS AMONG DRUG INJECTORS. ADDICTION RESEARCH, vol. 2(4), 351-362. link> doi>
  • GREEN S, FRISCHER M, TAYLOR A, GOLDBERG D, MCKEGANEY N, BLOOR M. 1995. INCREASING ECSTASY USE AMONG GLASGOW DRUG INJECTORS. ADDICTION RESEARCH, vol. 3(1), 73-76. link> doi>
  • BLOOR M, FRISCHER M, TAYLOR A, COVELL R, GOLDBERG D, GREEN S, MCKEGANEY N, PLATT S. 1994. TIDELINE AND TURN - POSSIBLE REASONS FOR THE CONTINUING LOW HIV PREVALENCE AMONG GLASGOW INJECTING DRUG-USERS. SOCIOLOGICAL REVIEW, vol. 42(4), 738-757. link>
  • Goldberg DJ, Frischer M, Taylor A, Green ST, McKeganey N, Bloor M, Reid D, Cossar J. 1994. Mobility of Scottish injecting drug users and risk of HIV infection. Eur J Epidemiol, vol. 10(4), 387-392. link> doi>
  • Green ST, Goldberg DJ, Carr SV, Taylor A, Frischer M, Gruer L. 1994. The value of acute medical services sited adjacent to areas of high drug-injecting activity. Addiction, vol. 89(6), 763-764. link> doi>
  • Goldberg D, Green ST, Taylor A, Frischer M, McKeganey N. 1994. Comparison of four survey methods designed to estimate the prevalence of HIV among female prostitutes who inject drugs. Int J STD AIDS, vol. 5(3), 186-188. link>
  • Taylor A, Frischer M, Green ST, Goldberg D, McKeganey N, Gruer L. 1994. Low and stable prevalence of HIV among drug injectors in Glasgow. Int J STD AIDS, vol. 5(2), 105-107. link>
  • FRISCHER M, GOLDBERG D, GREEN S, BLOOR M, CLARK J, MCKEGANEY N. 1994. LONGITUDINAL AND CROSS-SECTIONAL MORTALITY STUDIES IN INJECTING DRUG-USERS - REPLY. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, vol. 48(1), 101. link>
  • Angus BJ, Green ST, McKinley JJ, Goldberg DJ, Frischer M. 1994. Eikinella corrodens septicaemia among drug injectors: a possible association with 'licking wounds'. J Infect, vol. 28(1), 102-103. link> doi>
  • Frischer M, Elliott L, Taylor A, Goldberg D, Green S, Gruer L, Cameron J, McKeganey N, Bloor M. 1993. Do needle exchanges help to control the spread of HIV among injecting drug users?. AIDS, vol. 7(12), 1677-1678. link> doi>
  • Green ST, Taylor A, Frischer M, Goldberg DJ. 1993. 'Frontloading' ('halfing') among Glasgow drug injectors as a continuing risk behaviour for HIV transmission. Addiction, vol. 88(11), 1581-1582. link> doi>
  • Taylor A, Frischer M, McKeganey N, Goldberg D, Green S, Platt S. 1993. HIV risk behaviours among female prostitute drug injectors in Glasgow. Addiction, vol. 88(11), 1561-1564. link> doi>
  • Taylor A, Goldberg D, Frischer M, Emslie J, Green S, McKeganey N. 1993. Transmission of HIV in prison. Evidence of risk. BMJ, vol. 307(6904), 623. link>
  • Frischer M, Leyland A, Cormack R, Goldberg DJ, Bloor M, Green ST, Taylor A, Covell R, McKeganey N, Platt S. 1993. Estimating the population prevalence of injection drug use and infection with human immunodeficiency virus among injection drug users in Glasgow, Scotland. Am J Epidemiol, vol. 138(3), 170-181. link>
  • Frischer M, Bloor M, Goldberg D, Clark J, Green S, McKeganey N. 1993. Mortality among drug injectors and notified addicts. J Epidemiol Community Health, vol. 47(4), 336. link> doi>
  • Frischer M and Elliott L. 1993. Discriminating needle exchange attenders from non-attenders. Addiction, vol. 88(5), 681-687. link> doi>
  • Frischer M, Green S, Goldberg D. 1993. Prevalence of injecting drug use provides the context for epidemiology of HIV among injecting drug users. AIDS, vol. 7(3), 442-443. link> doi>
  • Covell RG, Frischer M, Taylor A, Goldberg D, Green S, McKeganey N, Bloor M. 1993. Prison experience of injecting drug users in Glasgow. Drug Alcohol Depend, vol. 32(1), 9-14. link> doi>
  • Goldberg D, Frischer M, Green ST. 1993. Sex surveys and drug users. Nature, vol. 361(6412), 504-505. link> doi>
  • Goldberg DJ, Tappin DM, Cameron S, Frischer M, Green ST, Follett EA. 1993. Saliva and HIV testing. Lancet, vol. 341(8841), 382. link> doi>
  • Frischer M, Bloor M, Goldberg D, Clark J, Green S, McKeganey N. 1993. Mortality among injecting drug users: a critical reappraisal. J Epidemiol Community Health, vol. 47(1), 59-63. link> doi>
  • Green ST, Goldberg DJ, Christie PR, Frischer M, Thomson A, Carr SV, Taylor A. 1993. Female streetworker--prostitutes in Glasgow: a descriptive study of their lifestyle. AIDS Care, vol. 5(3), 321-335. link> doi>
  • Rhodes TJ, Bloor MJ, Donoghoe MC, Haw S, Ettore B, Platt S, Frischer M, Hunter GM, Taylor A, Finlay A. 1993. HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow. AIDS Care, vol. 5(4), 413-425. link> doi>
  • Covell R, Follett E, Coote I, Bloor M, Finlay A, Frischer M, Goldberg D, Green S, Haw S, McKeganey N. 1993. HIV testing among injecting drug users in Glasgow. J Infect, vol. 26(1), 27-31. link> doi>
  • Frischer M, Haw S, Bloor M, Goldberg D, Green S, McKeganey N, Covell R. 1993. Modeling the behavior and attributes of injecting drug users: a new approach to identifying HIV risk practices. Int J Addict, vol. 28(2), 129-152. link>
  • Carr SV, Green ST, Goldberg DJ, Cameron S, Gruer L, Frischer M, Mackie T, Follett E. 1992. HIV prevalence among female street prostitutes attending a health-care drop-in centre in Glasgow. AIDS, vol. 6(12), 1553-1554. link>
  • Frischer M, Green ST, Goldberg DJ, Haw S, Bloor M, McKeganey N, Covell R, Taylor A, Gruer LD, Kennedy D. 1992. Estimates of HIV infection among injecting drug users in Glasgow, 1985-1990. AIDS, vol. 6(11), 1371-1375. link> doi>
  • Green ST, Nathwani D, Ralston S, Goldberg DJ, Frischer M, McMenemin J, Kennedy DH. 1992. Musculoskeletal symptomatology in some HIV-positive injecting drug users may be a manifestation of the benzodiazepine withdrawal syndrome. J Infect, vol. 25(3), 330-332. link> doi>
  • Frischer M, Bloor M, Green S, Goldberg D, Covell R, McKeganey N, Taylor A. 1992. Reduction in needle sharing among community wide samples of injecting drug users. Int J STD AIDS, vol. 3(4), 288-290. link>
  • FRISCHER M. 1992. ESTIMATING PREVALENCE OF INJECTING DRUG-USE IN AN URBAN-POPULATION - LIMITATIONS OF THE 3-SAMPLE ESTIMATION PROCEDURE - REPLY. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, vol. 21(3), 613-614. link> doi>
  • Green S, Goldberg D, Frischer M, McKeganey N. 1992. Triazolam as a substance of abuse among injecting drug users. Br J Addict, vol. 87(6), 940-941. link>
  • Haw S, Frischer M, Donoghoe M, Green S, Crosier A, Hunter G, Finlay A, Covell R, Ettmore B, Bloor M. 1992. The importance of multisite sampling in determining the prevalence of HIV among drug injectors in Glasgow and London. AIDS, vol. 6(5), 517-518. link>
  • Frischer M and Leyland A. 1992. Reliability of population and prevalence estimates. Lancet, vol. 339(8799), 995. link> doi>
  • Frischer M. 1992. Estimated prevalence of injecting drug use in Glasgow. Br J Addict, vol. 87(2), 235-243. link>
  • Frischer M, Bloor M, Finlay A, Goldberg D, Green S, Haw S, McKeganey N, Platt S. 1991. A new method of estimating prevalence of injecting drug use in an urban population: results from a Scottish city. Int J Epidemiol, vol. 20(4), 997-1000. link> doi>
  • Frischer M. 1991. Trends in morbidity and general practitioners' workload for middle-aged and elderly people from 1956 to 1982. J Public Health Med, vol. 13(3), 198-203. link>
  • Frischer M. 1989. Voluntary vs autonomous control of repetitive finger tapping in a patient with Parkinson's disease. Neuropsychologia, vol. 27(10), 1261-1266. link> doi>

Chapters

  • Frisher M, Crome I, Martino O, Bashford J. 2009. Epidemiology of drug misuse and psychiatric comorbidity in primary care. In MacGregor S. Responding to Drug misuse. Research and Policy Priorities in Health and Social Care. London & New York, Routlege, Taylor and Francis Group.
  • Frisher M, Crome I, Martino,O.,Croft,P,Bashford,J.. 2009. Epidemiology of Drug misuse and psychiatric comorbidity in Primary care. In Responding to Drugs Misuse: Research and Policy Priorities in Health and Social Care. (2009th ed.). S McGregor Ed.
  • Frisher M, McArdle P, Crome I. 2004. The epidemiology of substance misuse recorded in young people. In Young people and substance misuse. Crome I, Ghodse AH, al EGE (Eds.). London: Gaskell.
  • Frischer M and Heatlie HF. 2001. Modelling drug misuse in Europe using geographic information systems. In Modelling drug use: methods to quantify and understand hidden processes. Sharp F and Neaman R (Eds.). Luxembourg: Office for Official Publications of the EC.
  • Frischer M and Heatlie H. 2001. Modelling drug use: methods to quantify and understand hidden processes. In Modelling drug misuse in Europe using geographic information systems. Sharp F and Neaman R (Eds.). Office for Official Publications of the EC, Luxenburg.
  • Millson DS, Ward H, Clark W, Frischer M. 2000. Cost-effectiveness of migraine therapy: evaluating new acute treatments. In The Effective Mangement of Headache. Goadsby PJ, Dowson A, Miles A (Eds.). London: Aesculapius Medical Press.
  • Frischer M and Chapman S. 1998. Issues and directions in prescribing analysis. In Medicines Managemengt. Panton RS and Chapman S (Eds.). London: BMJ Books.
  • Frischer M. 1998. Mobility, migration and drug injecting. In Drug injecting and HIV infection: global dimensions and local responses. Stimson G, Des Jarlais D, Ball A (Eds.). London: UCL Press.
  • Des Jarlais D, Friedman S, Friedman P, Goldberg D, Frischer M, Green S. 1998. Preventing epidemics of HIV-1 among injecting drug users. In Drug injecting and HIV infection: global dimensions and local responses. Stimson G, Des Jarlais D, Ball A (Eds.). London: UCL Press.
  • Frischer M. 1997. Studies on registration of drug related death in Europe. In Drug related death in Europe. Danish National Board of Health.
  • Frischer M. 1997. Estimating the prevalence of drug use using the mortality multiplier method. In Estimating the prevalence of drug misuse in Europe. Stimson G, Hickman M, Quirk A, Frischer M (Eds.).
  • Frischer M. 1997. More complex capture-recapture models: an illustrative case study using data from ?. In Estimating the prevalence of drug misuse in Europe. Stimson G, Hickman M, Quirk A, Frischer M (Eds.).

Other

  • Coxon DE, Frisher M, Jordan KP, Jinks C, Peat G. 2012. DECIDING TO CONSULT THE GENERAL PRACTITIONER FOR SYMPTOMATIC OSTEOARTHRITIS: A CHOICE-BASED CONJOINT ANALYSIS STUDY. RHEUMATOLOGY (vol. 51, p. 37). link>
  • Frisher M, Baldacchino A, Crome I, Bloor R. 2012. Preventing opioid overdoses in Europe: a critical assessment of known risk factors and preventative measures. link>
  • FRISHER M, Bloor R, Crome I, Macleod J. 2007. Predictive factors for illicit drug use among young people: a literature review.
  • Frischer M, Heatlie HF, Hickman M. 2006. Estimating the prevalence of problematic and injecting drug use for Drug Action Team areas in England.
  • Frischer M and Heatlie HF. 2006. Psychiatric research using General Practice Data.
  • FRISCHER M, CROME I, CROFT P, MILLSON DS, COLLINS J, CONOLLY A. 2003. A national epidemiological study of comorbid substance abuse and psychiatric illness in primary care between 1993-1998 using the General Practice Research Database.
  • Frisher M. 2005. Drug Use: Commentary on "Recent Spread of Heroin Use in the United States" by Leon G Hunt.
  • FRISCHER M, HEATLIE HF, HICKMAN M. 2004. Estimated prevalence of problematic and injecting drugs use: Survey of Drug Action Teams in England.
  • BECKETT H, FRISHER M, HEAP J, MCARDLE P, ET AL. 2004. Understanding problem drug use among young people accessing drug services: A multivariate approach using statistical modelling techniques.
  • Frischer M, Crome I, Croft P, Millson DS, Collins J, Conolly A. 2003. A national epidemiological study of comorbid substance abuse and psychiatric illness in primary care between 1993-1998 using the GPRD.
  • Frischer M, Heatlie H, Hickman M. 2003. Estimating the prevalence of problematic and injecting drug use for drug action team areas in England: A feasibility study using the multiple indicator method.
  • Frischer M. 2003. Part 2: Epidemiological situation: Prevalence, patterns and developments in drug use.
  • BECKETT H, HEAP J, McARDLE P, GILVARRY E, CHRISTIAN J, BLOOR R, CROME I, FRISCHER M. 2003. Precursors and consequences of problematic drug use: A study of young people accessing designated drug services.
  • Crome I, Short D, Stevens C, Heatlie HF, Frischer M. 2002. Addiction Abstracts Review.
  • Anderson S and Frischer M. 2000. Drug misuse in Scotland: findings from the 1993 and 1996 Scottish crime surveys.
  • Frischer M. 1999. Study to obtain comparable national estimates of problem drug use prevalence for all EU member states.
  • Frischer M and Heatlie HF. 1999. Pilot project to develop a model of geographical spread of drug misuse in the Europen Union.
  • Short D, Chapman S, Frischer M. 1999. How should the transition to CFC-free inhalers be managed?.
  • Frischer M and Taylor A. 1999. Issues in assessing the nature and extent of local drug misuse.
  • Frischer M and Heatlie HF. 1998. European network to develop policy relevant models of drug use, consequences and interventions.
  • Frischer M and Heatlie HF. 1998. Pilot project to develop a model of geographical spread of drug misuse in the European Union.
  • Frischer M and Heatlie HF. 1997. Modelling drug misuse in Europe using geographical information systems.
  • Anderson S and Frischer M. 1997. Drug misuse in Scotland: findings from the 1993 and 1996 Scottish crime surveys.
  • Frischer M, Davies T, Haw S, Taylor A, Goldberg D. 1997. Injecting drug use in three Scottish cities: HIV infection and risk behaviour.
  • Frischer M, Taylor A, Barr C. 1997. Estimates of drug use prevalence in Ayrshire and Arran.
  • Frischer M. 1996. Estimating the prevalence of drug misuse in Scotland: a critical review and practical guide.
  • Taylor C, Frischer M, Goldberg D. 1996. Self reported illnesses and overdosing among Glasgow drug injectors.
  • Frischer M, Taylor A, Goldberg D. 1996. Travel and risk of HIV risk among Glasgow drug injectors.
  • GOLDBERG D, FRISCHER M, GREEN S, BLOOR M, MCKEGANEY N, PLATT S, COVELL R, TAYLOR A. 1992. THE WHO BEHAVIOURAL AND HIV PREVALENCE STUDY OF INJECTING DRUG USERS. 36TH INTERNATIONAL CONGRESS ON ALCOHOL AND DRUG DEPENDENCE, VOLS I & II (pp. 102-106). link>
  • ELLIOT L and FRISCHER M. 1992. WHAT DISTINGUISHES NEEDLE EXCHANGE ATTENDERS FROM NON-ATTENDERS. 36TH INTERNATIONAL CONGRESS ON ALCOHOL AND DRUG DEPENDENCE, VOLS I & II (pp. 56-59). link>